Quantcast

Latest Respiratory physiology Stories

2014-09-10 12:28:55

Respiratory Monitoring Helps to Protect Patients during Procedural Sedation GLENDALE, Calif., Sept. 10, 2014 /PRNewswire/ -- Glendale Adventist Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients during moderate sedation. Sedation provides comfort to the patient while maintaining a level of responsiveness (e.g., groggy but will respond to talking or pain), as opposed to general anesthesia where the patient is completely...

2014-09-08 12:30:18

Additionally, data from the WISDOM trial on stepwise withdrawal of ICS in COPD was also presented at ERS and simultaneously published in the New England Journal of Medicine RIDGEFIELD, Conn., Sept. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim today presented the first data from the pivotal Phase III TONADO(TM) 1&2 studies (NCT01431274/NCT01431287) for the fixed-dose combination (FDC) of tiotropium plus olodaterol delivered via the Respimat(®) inhaler in patients with moderate to...

2014-09-08 08:29:55

-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically significant superiority in post dose trough FEV1 after 26 weeks of treatment in patients with moderate-to-severe COPD1 -- In addition, LANTERN study met an endpoint demonstrating that Ultibro®Breezhaler ® reduced...

2014-07-29 12:35:21

WARRINGTON, Pa., July 29, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard of respiratory critical care, will report its second quarter 2014 financial results on August 5, 2014 before the open of the U.S. financial markets. The Company will host a live teleconference and webcast at 9:00 a.m. Eastern Time that same day. During the conference call, Discovery Labs' management will discuss the...

2014-07-24 08:31:52

ANDOVER, Mass., July 24, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro(®) has been chosen as the instrument to measure Carbon Monoxide Diffusing Capacity (DLCO) for phase 2 of the COPDGene(®) Study, the most comprehensive study of Chronic Obstructive Pulmonary Disease (COPD) ever undertaken. COPD is now the third leading cause of death in the U.S....

Outdoor Time Promotes Physical Activity In Youth
2014-07-10 03:06:25

Elsevier Health Sciences The World Health Organization recommends that youth participate in a minimum of 60 minutes of moderate to vigorous physical activity (MVPA) each day. Studies have shown that youth experience most of their MVPA during school hours. Therefore, it stands to reason that increasing outdoor time after school hours would increase MVPA. In a new study scheduled for publication in The Journal of Pediatrics, researchers confirmed that time spent outdoors after school was...

2014-07-01 23:02:12

Transparency Market Research has published a new report titled "Hemoglobin A1c Testing Devices Market: Global Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html. Albany, New York (PRWEB) July 01, 2014 According to a new market report published by Transparency Market Research "Hemoglobin A1c Testing Devices Market (End-use-Laboratory and...

2014-07-01 11:31:24

American Thoracic Society In a new study of the causes underlying respiratory symptoms in military personnel returning from duty in Iraq and Afghanistan, a large percentage of veterans had non-specific symptoms that did not lead to a specific clinical diagnosis. Most patients who did receive a diagnosis had evidence of asthma or nonspecific airway hyperreactivity, which may have been due in some cases to aggravation of pre-existing disease by deployment exposures. "Earlier studies of...

2014-06-17 08:29:40

WARRINGTON, Pa., June 17, 2014 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO) today announced that it has been awarded the final $1.9 million of a $2.4 million Fast Track Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). This award will provide support for the ongoing phase 2a clinical trial for AEROSURF®, Discovery Labs' investigational combination drug/device product....

2014-06-16 09:18:08

Stanford University Medical Center The first large-scale, comprehensive analysis of the genomic diversity of Mexico — led by researchers at the Stanford University School of Medicine, the University of California-San Francisco and the Mexican National Institute of Genomic Medicine — has identified a dazzling mosaic of genotypes and population substructures across the country. Some groups are as genetically different from one another as Europeans are from East Asians. The study,...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related